XML 33 R16.htm IDEA: XBRL DOCUMENT v3.25.1
Other accounts receivable, net
 12 Months Ended
Dec. 31, 2024
Other Accounts Receivable Net  
Other accounts receivable, net

8. Other accounts receivable, net

 

An analysis of other accounts receivable as of December 31, 2024 and 2023 is detailed below:

 

            
   2024  2023
Current:            
  Credit cards  US$ 34,756   US$ 59,675 
  Benefits from suppliers    22,640     11,174 
  Affinity credit card    5,460     4,230 
  Cargo clients    4,453     4,633 
  Other accounts receivable    3,979     4,652 
  Insurance in recovery process    2,349     —   
  Other points of sales    946     1,014 
  Airport services    800     473 
  Travel agencies and insurance commissions    599     3,493 
  Employees    562     777 
  Marketing services    119     —   
Other current accounts receivable, gross    76,663     90,121 
  Allowance for expected credit losses    (628)    (877)
Other accounts receivable, net  US$ 76,035   US$ 89,244 

 

Accounts receivable has the following aging:

 

                                    
Days 

2024

Impaired

 

2024

Not impaired

 

Total

2024

  2023
Impaired		  2023
Not impaired		  Total
2023
0–30  US$ 459   US$ 57,657   US$ 58,116   US$ 677   US$ 73,923   US$ 74,600 
31–60    —       6,030     6,030     —       10,628     10,628 
61–90    —       5,861     5,861     —       435     435 
91-120    169     6,487     6,656     200     4,258     4,458 
   US$ 628   US$ 76,035   US$ 76,663   US$ 877   US$ 89,244   US$ 90,121 

 

The movement in the allowance for expected credit losses from December 31, 2022 to December 31, 2024 is as follows:

 

      
Balance as of December 31, 2022  US$ (809)
  Write-offs    1,262 
  Increase in allowance    (1,330)
Balance as of December 31, 2023    (877)
  Write-offs    1,067 
  Increase in allowance    (818)
Balance as of December 31, 2024  US$ (628)

 

The allowance for expected credit losses on accounts receivable is established in accordance with the approach disclosed at Note 1f) ii).